首页> 美国卫生研究院文献>Journal of Thoracic Disease >Overexpression of farnesoid X receptor in small airways contributes to epithelial to mesenchymal transition and COX-2 expression in chronic obstructive pulmonary disease
【2h】

Overexpression of farnesoid X receptor in small airways contributes to epithelial to mesenchymal transition and COX-2 expression in chronic obstructive pulmonary disease

机译:小气管中法尼醇X受体的过表达有助于慢性阻塞性肺疾病的上皮向间质转化和COX-2表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundEpithelial-mesenchymal transition (EMT) and cyclooxygenase-2 (COX-2) contribute to airway remodelling and inflammation in chronic obstructive pulmonary disease (COPD). Recent data suggest that the farnesoid X receptor (FXR), a nuclear receptor traditionally considered as bile acid-activated receptor, is also expressed in non-classical bile acids target tissues with novel functions beyond regulating bile acid homeostasis. This study aimed to investigate the potential role of FXR in the development of COPD, as well as factors that affect FXR expression.
机译:背景上皮间质转化(EMT)和环氧合酶2(COX-2)有助于慢性阻塞性肺疾病(COPD)的气道重塑和炎症。最新数据表明,法尼醇X受体(FXR)是一种传统上被认为是胆汁酸激活受体的核受体,它还在非经典胆汁酸靶组织中表达,其功能超出调节胆汁酸稳态的新功能。这项研究旨在调查FXR在COPD发生中的潜在作用,以及影响FXR表达的因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号